Jeroen Rovers, formerly managing director of DCprime of the Netherlands, has been named chief medical officer at Immunicum AB following the merger of the two companies in December 2020. Dr Rovers joined DCprime as CMO at the end of 2018 before moving up to managing director. Prior to DCprime, he was CMO at the cell therapy company Kiadis Pharma BV which is being acquired by Sanofi SA. Dr Rovers obtained his MD and PhD in medicine from Leiden University in the Netherlands.
Immunicum announced the appointment on 1 March 2021.
Copyright 2021 Evernow Publishing Ltd